Elucidating the exact pharmacological mechanism of action (MOA) of naturally transpiring compounds is usually demanding. Though Tarselli et al. (60) made the main de novo synthetic pathway to conolidine and showcased this naturally transpiring compound properly suppresses responses to both equally chemically induced and inflammation-derived pain, t